The non-invasive prenatal test (NIPT), developed to detect Down syndrome and other chromosomal abnormalities in unborn children, can also detect blood cancers. Not just in pregnant women but in everyone. This is because the test examines the DNA that is circulating in the blood – and that may include the genetic material of cancer cells.
Welcome to the Leuven Cancer Institute, the LKI. The LKI unites doctors, caretakers and researches of University Hospitals Leuven and the KU Leuven in their fight against cancer. The LKI strives to coordinate research, therapy and care in the best way possible. We invest in targeted projects and incorporate innovative technologies, spanning several domains of cancer.
Together we can achieve progress faster and play a leading role in the battle against cancer. Every ally, each partner makes us stronger. Thank you for your support.
Prof. dr. Michel Delforge, chairman of the LKI